Skip to Content

Optimizing Venetoclax Treatment of Acute Myeloid Leukemia

Download PQI pdf 0.21MB

Last Updated: September 4, 2025

By: Seema Patel, PharmD

About this PQI

The purpose of this document is to highlight processes for minimizing treatment delays for patients with acute myeloid leukemia (AML) on venetoclax and hypomethylating agent (HMA) therapy including optimization of venetoclax initiation and continued patient management.

More About This PQI

PQI in Action Articles:
PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI